HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
37 hedge funds and large institutions have $11.9M invested in Hepion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Holders
37
Holding in Top 10
–
Calls
$1.53M
Puts
$409K
Top Buyers
| 1 | +$72K | |
| 2 | +$67.2K | |
| 3 | +$62.4K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$49.6K |
| 5 |
HF
HRT Financial
New York
|
+$40K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$1.2M | |
| 3 | -$883K | |
| 4 |
Two Sigma Investments
New York
|
-$485K |
| 5 |
VF
Virtu Financial
New York
|
-$225K |